CATH Superfamily 1.10.1300.10
3'5'-cyclic nucleotide phosphodiesterase, catalytic domain
The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"3'5'-cyclic nucleotide phosphodiesterase, catalytic domain
".
FunFam 9: Phosphodiesterase
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 36 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
3',5'-cyclic-AMP phosphodiesterase activity GO:0004115
Catalysis of the reaction: adenosine 3',5'-cyclic phosphate + H2O = adenosine 5'-phosphate.
|
15 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(5 more) |
Drug binding GO:0008144
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
|
15 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(5 more) |
3',5'-cyclic-GMP phosphodiesterase activity GO:0047555
Catalysis of the reaction: guanosine 3',5'-cyclic phosphate + H2O = guanosine 5'-phosphate.
|
14 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(4 more) |
CGMP-stimulated cyclic-nucleotide phosphodiesterase activity GO:0004118
Catalysis of the reaction: nucleoside 3',5'-cyclic phosphate + H2O = nucleoside 5'-phosphate; catalytic activity is increased in the presence of cGMP.
|
13 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(3 more) |
CGMP binding GO:0030553
Interacting selectively and non-covalently with cGMP, the nucleotide cyclic GMP (guanosine 3',5'-cyclophosphate).
|
13 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(3 more) |
CGMP-stimulated cyclic-nucleotide phosphodiesterase activity GO:0004118
Catalysis of the reaction: nucleoside 3',5'-cyclic phosphate + H2O = nucleoside 5'-phosphate; catalytic activity is increased in the presence of cGMP.
|
4 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) Q922S4 (/IDA) |
CGMP-stimulated cyclic-nucleotide phosphodiesterase activity GO:0004118
Catalysis of the reaction: nucleoside 3',5'-cyclic phosphate + H2O = nucleoside 5'-phosphate; catalytic activity is increased in the presence of cGMP.
|
4 | O00408 (/TAS) O00408 (/TAS) O00408 (/TAS) P14099 (/TAS) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
4 | O00408 (/IPI) O00408 (/IPI) O00408 (/IPI) Q01062 (/IPI) |
CAMP binding GO:0030552
Interacting selectively and non-covalently with cAMP, the nucleotide cyclic AMP (adenosine 3',5'-cyclophosphate).
|
4 | O00408 (/IMP) O00408 (/IMP) O00408 (/IMP) Q922S4 (/IMP) |
CGMP binding GO:0030553
Interacting selectively and non-covalently with cGMP, the nucleotide cyclic GMP (guanosine 3',5'-cyclophosphate).
|
4 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) Q922S4 (/IDA) |
CGMP binding GO:0030553
Interacting selectively and non-covalently with cGMP, the nucleotide cyclic GMP (guanosine 3',5'-cyclophosphate).
|
4 | O00408 (/IMP) O00408 (/IMP) O00408 (/IMP) Q922S4 (/IMP) |
Magnesium ion binding GO:0000287
Interacting selectively and non-covalently with magnesium (Mg) ions.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
3',5'-cyclic-AMP phosphodiesterase activity GO:0004115
Catalysis of the reaction: adenosine 3',5'-cyclic phosphate + H2O = adenosine 5'-phosphate.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
Calcium channel activity GO:0005262
Enables the facilitated diffusion of a calcium ion (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.
|
3 | O00408 (/TAS) O00408 (/TAS) O00408 (/TAS) |
Drug binding GO:0008144
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
Drug binding GO:0008144
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
|
3 | O00408 (/IPI) O00408 (/IPI) O00408 (/IPI) |
Zinc ion binding GO:0008270
Interacting selectively and non-covalently with zinc (Zn) ions.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
TPR domain binding GO:0030911
Interacting selectively and non-covalently with a tetratricopeptide repeat (TPR) domain of a protein, the consensus sequence of which is defined by a pattern of small and large hydrophobic amino acids and a structure composed of helices.
|
3 | O00408 (/IPI) O00408 (/IPI) O00408 (/IPI) |
Phosphate ion binding GO:0042301
Interacting selectively and non-covalently with phosphate.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
3 | O00408 (/IPI) O00408 (/IPI) O00408 (/IPI) |
3',5'-cyclic-GMP phosphodiesterase activity GO:0047555
Catalysis of the reaction: guanosine 3',5'-cyclic phosphate + H2O = guanosine 5'-phosphate.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
2 | Q01062 (/IDA) Q922S4 (/IDA) |
Magnesium ion binding GO:0000287
Interacting selectively and non-covalently with magnesium (Mg) ions.
|
1 | Q922S4 (/ISO) |
3',5'-cyclic-AMP phosphodiesterase activity GO:0004115
Catalysis of the reaction: adenosine 3',5'-cyclic phosphate + H2O = adenosine 5'-phosphate.
|
1 | Q922S4 (/ISO) |
CGMP-stimulated cyclic-nucleotide phosphodiesterase activity GO:0004118
Catalysis of the reaction: nucleoside 3',5'-cyclic phosphate + H2O = nucleoside 5'-phosphate; catalytic activity is increased in the presence of cGMP.
|
1 | Q922S4 (/ISO) |
Drug binding GO:0008144
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
|
1 | Q922S4 (/ISO) |
Zinc ion binding GO:0008270
Interacting selectively and non-covalently with zinc (Zn) ions.
|
1 | Q922S4 (/ISO) |
CAMP binding GO:0030552
Interacting selectively and non-covalently with cAMP, the nucleotide cyclic AMP (adenosine 3',5'-cyclophosphate).
|
1 | Q922S4 (/ISO) |
CGMP binding GO:0030553
Interacting selectively and non-covalently with cGMP, the nucleotide cyclic GMP (guanosine 3',5'-cyclophosphate).
|
1 | Q922S4 (/ISO) |
CGMP binding GO:0030553
Interacting selectively and non-covalently with cGMP, the nucleotide cyclic GMP (guanosine 3',5'-cyclophosphate).
|
1 | P14099 (/TAS) |
TPR domain binding GO:0030911
Interacting selectively and non-covalently with a tetratricopeptide repeat (TPR) domain of a protein, the consensus sequence of which is defined by a pattern of small and large hydrophobic amino acids and a structure composed of helices.
|
1 | Q922S4 (/ISO) |
GAF domain binding GO:0036004
Interacting selectively and non-covalently with the GAF domain of a protein.
|
1 | Q922S4 (/IDA) |
Phosphate ion binding GO:0042301
Interacting selectively and non-covalently with phosphate.
|
1 | Q922S4 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
1 | Q922S4 (/ISO) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
1 | Q922S4 (/ISO) |
3',5'-cyclic-GMP phosphodiesterase activity GO:0047555
Catalysis of the reaction: guanosine 3',5'-cyclic phosphate + H2O = guanosine 5'-phosphate.
|
1 | Q922S4 (/ISO) |
There are 72 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
15 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(5 more) |
CGMP-mediated signaling GO:0019934
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic GMP (cGMP). Includes production of cGMP, and downstream effectors that further transmit the signal within the cell.
|
15 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(5 more) |
Cellular response to drug GO:0035690
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
15 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(5 more) |
Cellular response to macrophage colony-stimulating factor stimulus GO:0036006
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a macrophage colony-stimulating factor stimulus.
|
15 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(5 more) |
Negative regulation of vascular permeability GO:0043116
Any process that reduces the extent to which blood vessels can be pervaded by fluid.
|
15 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(5 more) |
Positive regulation of vascular permeability GO:0043117
Any process that increases the extent to which blood vessels can be pervaded by fluid.
|
15 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(5 more) |
Cellular response to cGMP GO:0071321
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cGMP (cyclic GMP, guanosine 3',5'-cyclophosphate) stimulus.
|
15 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(5 more) |
Cellular response to granulocyte macrophage colony-stimulating factor stimulus GO:0097011
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a granulocyte macrophage colony-stimulating factor stimulus.
|
15 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(5 more) |
CAMP-mediated signaling GO:0019933
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell.
|
14 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(4 more) |
Negative regulation of cAMP-mediated signaling GO:0043951
Any process which stops, prevents, or reduces the frequency, rate or extent of cAMP-mediated signaling, a series of molecular signals in which a cell uses cyclic AMP to convert an extracellular signal into a response.
|
14 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(4 more) |
CGMP catabolic process GO:0046069
The chemical reactions and pathways resulting in the breakdown of cyclic GMP, guanosine 3',5'-phosphate.
|
14 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(4 more) |
Positive regulation of inflammatory response GO:0050729
Any process that activates or increases the frequency, rate or extent of the inflammatory response.
|
11 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
O00408 (/ISS)
O00408 (/ISS)
O00408 (/ISS)
P14099 (/ISS)
(1 more) |
Establishment of endothelial barrier GO:0061028
The establishment of a barrier between endothelial cell layers, such as those in the brain, lung or intestine, to exert specific and selective control over the passage of water and solutes, thus allowing formation and maintenance of compartments that differ in fluid and solute composition.
|
11 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
O00408 (/ISS)
O00408 (/ISS)
O00408 (/ISS)
P14099 (/ISS)
(1 more) |
Cellular response to mechanical stimulus GO:0071260
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
11 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
O00408 (/ISS)
O00408 (/ISS)
O00408 (/ISS)
P14099 (/ISS)
(1 more) |
Negative regulation of cAMP-mediated signaling GO:0043951
Any process which stops, prevents, or reduces the frequency, rate or extent of cAMP-mediated signaling, a series of molecular signals in which a cell uses cyclic AMP to convert an extracellular signal into a response.
|
4 | O00408 (/IMP) O00408 (/IMP) O00408 (/IMP) Q922S4 (/IMP) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
Heart valve development GO:0003170
The progression of a heart valve over time, from its formation to the mature structure. A heart valve is a structure that restricts the flow of blood to different regions of the heart and forms from an endocardial cushion.
|
3 | O00408 (/ISS) O00408 (/ISS) O00408 (/ISS) |
Ventricular septum development GO:0003281
The progression of the ventricular septum over time from its formation to the mature structure.
|
3 | O00408 (/ISS) O00408 (/ISS) O00408 (/ISS) |
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
|
3 | O00408 (/TAS) O00408 (/TAS) O00408 (/TAS) |
Adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway GO:0007193
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through inhibition of adenylyl cyclase activity and a subsequent decrease in the concentration of cyclic AMP (cAMP).
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
CAMP-mediated signaling GO:0019933
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell.
|
3 | O00408 (/IMP) O00408 (/IMP) O00408 (/IMP) |
CGMP-mediated signaling GO:0019934
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic GMP (cGMP). Includes production of cGMP, and downstream effectors that further transmit the signal within the cell.
|
3 | O00408 (/IMP) O00408 (/IMP) O00408 (/IMP) |
Cellular response to drug GO:0035690
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
3 | O00408 (/IMP) O00408 (/IMP) O00408 (/IMP) |
Aorta development GO:0035904
The progression of the aorta over time, from its initial formation to the mature structure. An aorta is an artery that carries blood from the heart to other parts of the body.
|
3 | O00408 (/ISS) O00408 (/ISS) O00408 (/ISS) |
Cellular response to macrophage colony-stimulating factor stimulus GO:0036006
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a macrophage colony-stimulating factor stimulus.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
Negative regulation of vascular permeability GO:0043116
Any process that reduces the extent to which blood vessels can be pervaded by fluid.
|
3 | O00408 (/IMP) O00408 (/IMP) O00408 (/IMP) |
Positive regulation of vascular permeability GO:0043117
Any process that increases the extent to which blood vessels can be pervaded by fluid.
|
3 | O00408 (/IMP) O00408 (/IMP) O00408 (/IMP) |
CGMP catabolic process GO:0046069
The chemical reactions and pathways resulting in the breakdown of cyclic GMP, guanosine 3',5'-phosphate.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
Cellular response to cAMP GO:0071320
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
Cellular response to cGMP GO:0071321
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cGMP (cyclic GMP, guanosine 3',5'-cyclophosphate) stimulus.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
3 | O00408 (/IEP) O00408 (/IEP) O00408 (/IEP) |
Cellular response to 2,3,7,8-tetrachlorodibenzodioxine GO:1904613
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 2,3,7,8-tetrachlorodibenzodioxine stimulus.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
Regulation of mitochondrion organization GO:0010821
Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a mitochondrion.
|
2 | Q01062 (/IMP) Q922S4 (/IMP) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
2 | Q01062 (/IMP) Q922S4 (/IMP) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
1 | Q922S4 (/ISO) |
Heart valve development GO:0003170
The progression of a heart valve over time, from its formation to the mature structure. A heart valve is a structure that restricts the flow of blood to different regions of the heart and forms from an endocardial cushion.
|
1 | Q922S4 (/IMP) |
Cardiac septum development GO:0003279
The progression of a cardiac septum over time, from its initial formation to the mature structure.
|
1 | Q922S4 (/IMP) |
Ventricular septum development GO:0003281
The progression of the ventricular septum over time from its formation to the mature structure.
|
1 | Q922S4 (/IMP) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
1 | P14099 (/NAS) |
Adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway GO:0007193
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through inhibition of adenylyl cyclase activity and a subsequent decrease in the concentration of cyclic AMP (cAMP).
|
1 | Q922S4 (/ISO) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | Q922S4 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | Q922S4 (/IMP) |
Regulation of nitric oxide mediated signal transduction GO:0010749
Any process that modulates the rate, frequency or extent of nitric oxide mediated signal transduction. Nitric oxide mediated signal transduction is a series of molecular signals mediated by the detection of nitric oxide (NO).
|
1 | Q922S4 (/IGI) |
Regulation of mitochondrion organization GO:0010821
Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a mitochondrion.
|
1 | Q922S4 (/ISO) |
CAMP-mediated signaling GO:0019933
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell.
|
1 | Q922S4 (/IDA) |
CAMP-mediated signaling GO:0019933
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell.
|
1 | Q922S4 (/ISO) |
CAMP-mediated signaling GO:0019933
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell.
|
1 | Q922S4 (/NAS) |
CGMP-mediated signaling GO:0019934
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic GMP (cGMP). Includes production of cGMP, and downstream effectors that further transmit the signal within the cell.
|
1 | Q922S4 (/IDA) |
CGMP-mediated signaling GO:0019934
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic GMP (cGMP). Includes production of cGMP, and downstream effectors that further transmit the signal within the cell.
|
1 | Q922S4 (/ISO) |
CGMP-mediated signaling GO:0019934
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic GMP (cGMP). Includes production of cGMP, and downstream effectors that further transmit the signal within the cell.
|
1 | Q922S4 (/NAS) |
Cellular response to drug GO:0035690
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | Q922S4 (/ISO) |
Aorta development GO:0035904
The progression of the aorta over time, from its initial formation to the mature structure. An aorta is an artery that carries blood from the heart to other parts of the body.
|
1 | Q922S4 (/IMP) |
Cellular response to macrophage colony-stimulating factor stimulus GO:0036006
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a macrophage colony-stimulating factor stimulus.
|
1 | Q922S4 (/ISO) |
Negative regulation of vascular permeability GO:0043116
Any process that reduces the extent to which blood vessels can be pervaded by fluid.
|
1 | Q922S4 (/ISO) |
Positive regulation of vascular permeability GO:0043117
Any process that increases the extent to which blood vessels can be pervaded by fluid.
|
1 | Q922S4 (/ISO) |
Negative regulation of cAMP-mediated signaling GO:0043951
Any process which stops, prevents, or reduces the frequency, rate or extent of cAMP-mediated signaling, a series of molecular signals in which a cell uses cyclic AMP to convert an extracellular signal into a response.
|
1 | Q01062 (/IDA) |
Negative regulation of cAMP-mediated signaling GO:0043951
Any process which stops, prevents, or reduces the frequency, rate or extent of cAMP-mediated signaling, a series of molecular signals in which a cell uses cyclic AMP to convert an extracellular signal into a response.
|
1 | Q922S4 (/ISO) |
GMP catabolic process GO:0046038
The chemical reactions and pathways resulting in the breakdown of GMP, guanosine monophosphate.
|
1 | P14099 (/NAS) |
GMP catabolic process GO:0046038
The chemical reactions and pathways resulting in the breakdown of GMP, guanosine monophosphate.
|
1 | P14099 (/TAS) |
CGMP catabolic process GO:0046069
The chemical reactions and pathways resulting in the breakdown of cyclic GMP, guanosine 3',5'-phosphate.
|
1 | Q922S4 (/ISO) |
Positive regulation of inflammatory response GO:0050729
Any process that activates or increases the frequency, rate or extent of the inflammatory response.
|
1 | Q922S4 (/IMP) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
1 | Q922S4 (/ISO) |
Coronary vasculature development GO:0060976
The process whose specific outcome is the progression of the blood vessels of the heart over time, from its formation to the mature structure.
|
1 | Q922S4 (/IMP) |
Establishment of endothelial barrier GO:0061028
The establishment of a barrier between endothelial cell layers, such as those in the brain, lung or intestine, to exert specific and selective control over the passage of water and solutes, thus allowing formation and maintenance of compartments that differ in fluid and solute composition.
|
1 | Q01062 (/IDA) |
Establishment of endothelial barrier GO:0061028
The establishment of a barrier between endothelial cell layers, such as those in the brain, lung or intestine, to exert specific and selective control over the passage of water and solutes, thus allowing formation and maintenance of compartments that differ in fluid and solute composition.
|
1 | Q922S4 (/ISO) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | Q922S4 (/IEP) |
Cellular response to mechanical stimulus GO:0071260
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | Q922S4 (/IDA) |
Cellular response to cAMP GO:0071320
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
|
1 | Q922S4 (/ISO) |
Cellular response to cGMP GO:0071321
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cGMP (cyclic GMP, guanosine 3',5'-cyclophosphate) stimulus.
|
1 | Q922S4 (/ISO) |
Cellular response to granulocyte macrophage colony-stimulating factor stimulus GO:0097011
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a granulocyte macrophage colony-stimulating factor stimulus.
|
1 | Q922S4 (/ISO) |
Cellular response to 2,3,7,8-tetrachlorodibenzodioxine GO:1904613
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 2,3,7,8-tetrachlorodibenzodioxine stimulus.
|
1 | Q922S4 (/ISO) |
Response to hydrogen sulfide GO:1904880
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen sulfide stimulus.
|
1 | Q01062 (/IEP) |
There are 36 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
14 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(4 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
14 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(4 more) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
14 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
G1S5U6 (/ISS)
G1U4Q4 (/ISS)
G3RFB4 (/ISS)
G5AS68 (/ISS)
(4 more) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
11 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
O00408 (/ISS)
O00408 (/ISS)
O00408 (/ISS)
P14099 (/ISS)
(1 more) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
11 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
O00408 (/ISS)
O00408 (/ISS)
O00408 (/ISS)
P14099 (/ISS)
(1 more) |
Presynaptic membrane GO:0042734
A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane.
|
11 |
B3VTJ2 (/ISS)
D2HWN4 (/ISS)
F1SUV3 (/ISS)
F6Q8H8 (/ISS)
F6UGJ6 (/ISS)
F6Y625 (/ISS)
O00408 (/ISS)
O00408 (/ISS)
O00408 (/ISS)
P14099 (/ISS)
(1 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
8 | B3VTJ2 (/ISS) D2HWN4 (/ISS) F1SUV3 (/ISS) F6Q8H8 (/ISS) F6UGJ6 (/ISS) F6Y625 (/ISS) P14099 (/ISS) Q01062 (/ISS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
7 | B3VTJ2 (/IDA) F6Y625 (/IDA) O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) Q01062 (/IDA) Q922S4 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
5 | D2HWN4 (/ISS) F1SUV3 (/ISS) F6Q8H8 (/ISS) F6UGJ6 (/ISS) P14099 (/ISS) |
Mitochondrial outer membrane GO:0005741
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
|
5 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) Q01062 (/IDA) Q922S4 (/IDA) |
Mitochondrial inner membrane GO:0005743
The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae.
|
5 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) Q01062 (/IDA) Q922S4 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
4 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) Q01062 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
4 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) Q922S4 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
4 | G1U4Q4 (/IDA) O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
3 | O00408 (/TAS) O00408 (/TAS) O00408 (/TAS) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
3 | O00408 (/IDA) O00408 (/IDA) O00408 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | Q922S4 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | Q922S4 (/ISO) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
1 | Q922S4 (/IDA) |
Mitochondrial outer membrane GO:0005741
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
|
1 | Q922S4 (/ISO) |
Mitochondrial inner membrane GO:0005743
The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae.
|
1 | Q922S4 (/ISO) |
Mitochondrial matrix GO:0005759
The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation.
|
1 | Q01062 (/IDA) |
Mitochondrial matrix GO:0005759
The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation.
|
1 | Q922S4 (/ISO) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
1 | Q922S4 (/IDA) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
1 | Q922S4 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
1 | Q922S4 (/ISO) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
1 | Q922S4 (/ISO) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
1 | Q922S4 (/IDA) |
Dendrite GO:0030425
A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
|
1 | Q922S4 (/IDA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
1 | Q01062 (/IDA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
1 | Q922S4 (/ISO) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
1 | Q922S4 (/ISO) |
Synaptic membrane GO:0097060
A specialized area of membrane on either the presynaptic or the postsynaptic side of a synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell.
|
1 | Q01062 (/IDA) |
Synaptic membrane GO:0097060
A specialized area of membrane on either the presynaptic or the postsynaptic side of a synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell.
|
1 | Q922S4 (/ISO) |
Hippocampal mossy fiber GO:0097457
Axon of dentate gyrus granule cell projecting to hippocampal area CA3, characterized by expansions (mossy fiber expansions) giving the fibers a mossy appearance. These unmyelinated axons were first described by Ramon y Cajal.
|
1 | Q01062 (/IDA) |
Hippocampal mossy fiber GO:0097457
Axon of dentate gyrus granule cell projecting to hippocampal area CA3, characterized by expansions (mossy fiber expansions) giving the fibers a mossy appearance. These unmyelinated axons were first described by Ramon y Cajal.
|
1 | Q922S4 (/ISO) |